Keywords
1. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev. 2013; 26(4):822-80. https://doi.org/10.1128/CMR.00022-13 | ||||
2. Boll EJ, Struve C, Boisen N, Olesen B, Stahlhut SG, Krogfelt KA. Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis. Infect Immun. 2013; 81(4):1164-71. https://doi.org/10.1128/IAI.01376-12 | ||||
3. Dormanesh B, Dehkordi FS, Hosseini S, Momtaz H, Mirnejad R, Hoseini MJ, et al. Virulence factors and o-serogroups profiles of uropathogenic Escherichia coli isolated from Iranian pediatric patients. Iranian Red Crescent Med J. 2014; 16(2):e14627. https://doi.org/10.5812/ircmj.14627 | ||||
4. Tapader R, Chatterjee S, Singh A, Dayma P, Haldar S, Pal A, et al. The high prevalence of serine protease autotransporters of Enterobacteriaceae (SPATEs) in Escherichia coli causing neonatal septicemia. Eur J Clin Microbiol Infect Dis. 2014; 33(11):2015-24. https://doi.org/10.1007/s10096-014-2161-4 | ||||
5. Bhullar K, Zarepour M, Yu H, Yang H, Croxen M, Stahl M, et al. The serine protease autotransporter pic modulates citrobacter rodentium pathogenesis and its innate recognition by the host. Infect Immun. 2015; 83(7):2636-50. https://doi.org/10.1128/IAI.00025-15 | ||||
6. Brzuszkiewicz E, Thürmer A, Schuldes J, Leimbach A, Liesegang H, Meyer F-D, et al. Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC). Arch Microbiol. 2011; 193(12):883-91. https://doi.org/10.1007/s00203-011-0725-6 | ||||
7. Ahn JY, Song JE, Kim MH, Choi H, Kim JK, Ann HW, et al. Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: A matched case-control study. Am J Infect Control. 2014; 42(6):621-5. https://doi.org/10.1016/j.ajic.2014.02.024 | ||||
8. Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 2013; 57(3):1488-95. https://doi.org/10.1128/AAC.01823-12 | ||||
9. Xie J, Peters BM, Li B, Li L, Yu G, Xu Z, et al. Clinical features and antimicrobial resistance profiles of important Enterobacteriaceae pathogens in Guangzhou representative of Southern China, 2001–2015. Microb Pathog. 2017; 107:206-11 https://doi.org/10.1016/j.micpath.2017.03.038 | ||||
10. Wong MH, Xie M, Xie L, Lin D, Li R, Zhou Y, et al. Complete sequence of a F33: A-: B-conjugative plasmid carrying the oqxAB, fosA3, and blaCTX-M-55 elements from a foodborne Escherichia coli strain. Front Microbiol. 2016; 7:1729. https://doi.org/10.3389/fmicb.2016.01729 | ||||
11. Bogaerts P, Bouchahrouf W, Rezende R, Deplano A, Berhin C, Piérard D, et al. Emergence of NDM-1-producing Enterobacteriaceae in Belgium. Antimicrob Agents Chemother. 2011; 55(6):3036-8. https://doi.org/10.1128/AAC.00049-11 | ||||
12. Robicsek A, Strahilevitz J, Sahm D, Jacoby G, Hooper D. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006; 50(8):2872-4. https://doi.org/10.1128/AAC.01647-05 | ||||
13. Karch H, Huppertz H-I, Bockemühl J, Schmidt H, Schwarzkopf A, Lissner R. Shiga toxin-producing Escherichia coli infections in Germany. J Food Prot. 1997; 60(11):1454-7. https://doi.org/10.4315/0362-028X-60.11.1454 | ||||
14. Raisch J, Buc E, Bonnet M, Sauvanet P, Vazeille E, De Vallée A, et al. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol: WJG. 2014; 20(21):6560. https://doi.org/10.3748/wjg.v20.i21.6560 | ||||
15. Ewers C, Li G, Wilking H, Kieβling S, Alt K, Antáo E-M, et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: How closely related are they? Int J Med Microbiol. 2007; 297(3):163-76. https://doi.org/10.1016/j.ijmm.2007.01.003 | ||||
16. Maurer JJ, Brown TP, Steffens W, Thayer SG. The occurrence of ambient temperature-regulated adhesins, curli, and the temperature-sensitive hemagglutinin tsh among avian Escherichia coli. Avian Dis. 1998; 42(1):106-18. https://doi.org/10.2307/1592582 | ||||
17. Nguyen N, Vafin R, Rzhanova I, Kolpakov A, Gataullin I, Tyulkin S, et al. Molecular genetic analysis of microorganisms with intraepithelial invasion isolated from patients with colorectal cancer. Mol Genet Microbiol Virol. 2016; 31(1):15-20. https://doi.org/10.3103/S0891416816010079 | ||||
18. Pullukcu H, Tasbakan M, Sipahi OR, Yamazhan T, Aydemir S, Ulusoy S. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections. Int J Antimicrob Agents. 2007; 29(1):62-5. https://doi.org/10.1016/j.ijantimicag.2006.08.039 | ||||
19. Oteo J, Bautista V, Lara N, Cuevas O, Arroyo M, Fernández S, et al. Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. J Antimicrob Chemother. 2010; 65(11):2459-63. https://doi.org/10.1093/jac/dkq346 | ||||
20. Alizade H, Fallah F, Ghanbarpour R, Aflatoonian MR, Goudarzi H, Sharifi H. Phylogenetic groups, extended-spectrum β-lactamases and metallo-β-lactamase in Escherichia coli isolated from fecal samples of patients with diarrhea in Iran. Gastroenterol Hepatol Bed Bench. 2015; 8(3):207. | ||||
21. Nobari S, Shahcheraghi F, Rahmati Ghezelgeh F, Valizadeh B. Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated from Iranian patients: First identification of blaKPC gene in Iran. Microb Drug Resist. 2014; 20(4):285-93. https://doi.org/10.1089/mdr.2013.0074 | ||||
22. Ho P, Cheung Y, Wang Y, Lo W, Lai E, Chow K, et al. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong. Eur J Clin Microbiol Infect Dis. 2016; 35(3):379-85. https://doi.org/10.1007/s10096-015-2550-3 | ||||
23. Stoesser N, Sheppard AE, Peirano G, Sebra RP, Lynch T, Anson LW, et al. First report of blaIMP-14 on a plasmid harboring multiple drug resistance genes in Escherichia coli sequence Type 131. Antimicrob Agents Chemother. 2016; 60(8):5068-71. https://doi.org/10.1128/AAC.00840-16 | ||||
24. Sidjabat HE, Heney C, George NM, Nimmo GR, Paterson DL. Interspecies transfer of blaIMP-4 in a patient with prolonged colonization by IMP-4-producing Enterobacteriaceae. J Clin Microbiol. 2014; 52(10):3816-8. https://doi.org/10.1128/JCM.01491-14 | ||||
25. Sidjabat HE, Robson J, Paterson DL. Draft genome sequences of two IMP-4-producing Escherichia coli sequence Type 131 isolates in Australia. Genome Announc. 2015; 3(4):e00983-15. https://doi.org/10.1128/genomeA.00983-15 | ||||
26. Netikul T, Sidjabat HE, Paterson DL, Kamolvit W, Tantisiriwat W, Steen JA, et al. Characterization of an IncN2-type blaNDM-1-carrying plasmid in Escherichia coli ST131 and Klebsiella pneumoniae ST11 and ST15 isolates in Thailand. J Antimicrob Chemother. 2014; 69(11):3161-3. https://doi.org/10.1093/jac/dku275 | ||||
27. Lin D, Xie M, Li R, Chen K, Chan EW-C, Chen S. IncFII conjugative plasmid-mediated transmission of blaNDM-1 elements among animal-borne Escherichia coli strains. Antimicrob Agents Chemother. 2017; 61(1):e02285-16. https://doi.org/10.1128/AAC.02285-16 | ||||
28. Shen P, Yi M, Fu Y, Ruan Z, Du X, Yu Y, et al. Detection of an Escherichia coli sequence Type 167 strain with two tandem copies of blaNDM-1 in the chromosome. J Clinical Microbiol. 2017; 55(1):199-205. https://doi.org/10.1128/JCM.01581-16 | ||||
29. Campos JC, da Silva MJF, dos Santos PRN, Barros EM, de Oliveira Pereira M, Seco BMS, et al. Characterization of Tn3000, a transposon responsible for blaNDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India. Antimicrob Agents Chemother. 2015; 59(12):7387-95. https://doi.org/10.1128/AAC.01458-15 | ||||
30. Sadeghi MR, Ghotaslou R, Akhi MT, Asgharzadeh M, Hasani A. Molecular characterization of extended-spectrum β-lactamase, plasmid-mediated AmpC cephalosporinase and carbapenemase genes among Enterobacteriaceae isolates in five medical centres of East and West Azerbaijan, Iran. J Med Microbiol. 2016; 65(11):1322-31. https://doi.org/10.1099/jmm.0.000356 | ||||
31. Witcomb LA, Collins JW, McCarthy AJ, Frankel G, Taylor PW. Bioluminescent imaging reveals novel patterns of colonization and invasion in systemic Escherichia coli K1 experimental infection in the neonatal rat. Infect Immun. 2015; 83(12):4528-40. https://doi.org/10.1128/IAI.00953-15 | ||||
32. Carl MA, Ndao IM, Springman AC, Manning SD, Johnson JR, Johnston BD, et al. Sepsis from the gut: The enteric habitat of bacteria that cause late-onset neonatal bloodstream infections. Clin Infect Dis. 2014; 58(9):1211-8. https://doi.org/10.1093/cid/ciu084 | ||||
33. Alerasol M, Gargari SLM, Nazarian S, Bagheri S. Immunogenicity of a fusion protein comprising coli surface Antigen 3 and Labile B subunit of enterotoxigenic Escherichia coli. Iran Biomed J. 2014; 18(4):212. | ||||
34. Fattahi S, Kafil HS, Nahai MR, Asgharzadeh M, Nori R, Aghazadeh M. Relationship of biofilm formation and different virulence genes in uropathogenic Escherichia coli isolates from Northwest Iran. GMS Hyg Infect Control. 2015; 10. | ||||
35. Štaudová B, Micenková L, Bosák J, Hrazdilová K, Slaninková E, Vrba M, et al. Determinants encoding fimbriae Type 1 in fecal Escherichia coli are associated with increased frequency of bacteriocinogeny. BMC Microbiol. 2015; 15(1):201. https://doi.org/10.1186/s12866-015-0530-5 | ||||
36. Jahandeh N, Ranjbar R, Behzadi P, Behzadi E. Uropathogenic Escherichia coli virulence genes: Invaluable approaches for designing DNA microarray probes. Cent European J Urol. 2015; 68(4):452. | ||||
37. Tabasi M, Karam MRA, Habibi M, Mostafavi E, Bouzari S. Genotypic characterization of virulence factors in Escherichia coli isolated from patients with acute cystitis, pyelonephritis and asymptomatic bacteriuria. J Clin Diagnostic Res. 2016;10(12). https://doi.org/10.7860/JCDR/2016/21379.9009 | ||||
38. López-Banda DA, Carrillo-Casas EM, Leyva-Leyva M, Orozco-Hoyuela G, Manjarrez-Hernández ÁH, Arroyo-Escalante S, et al. Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico. BioMed Res I nt. 2014; 2014:959206. | ||||
39. Toval F, Köhler C-D, Vogel U, Wagenlehner F, Mellmann A, Fruth A, et al. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J Clin Microbiol. 2014; 52(2):407-18. https://doi.org/10.1128/JCM.02069-13 | ||||
40. Shookohi M, Rashki A. Prevalence of toxigenic genes in Escherichia Coli isolates from hospitalized patients in Zabol, Iran. Int J Enteric Pathog. 2016; 4(1):e29222. https://doi.org/10.17795/ijep29222 | ||||